Clinical outcomes of patients with T4 or N1b well-differentiated thyroid cancer after different strategies of adjuvant radioiodine therapy

We aimed to determine whether recombinant human thyrotropin (rhTSH) plus 3.7 GBq could replace thyroid hormone withdrawal (THW) plus 5.55 GBq for adjuvant radioactive iodine (RAI) therapy in differentiated thyroid cancer (DTC) patients with T4 or N1b disease. This study was a retrospective study com...

Descripción completa

Detalles Bibliográficos
Autores principales: Jeong, Shin Young, Lee, Sang-Woo, Kim, Wan Wook, Jung, Jin Hyang, Lee, Won Kee, Ahn, Byeong-Cheol, Lee, Jaetae
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6447529/
https://www.ncbi.nlm.nih.gov/pubmed/30944403
http://dx.doi.org/10.1038/s41598-019-42083-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6447529/
https://www.ncbi.nlm.nih.gov/pubmed/30944403
http://dx.doi.org/10.1038/s41598-019-42083-3

Ejemplares similares